Early-bird registration is now available for the 2026 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit, scheduled for March 12-13 in Salt Lake City. The event, co-presented by BioUtah and Brigham Young University's College of Life Sciences and Technology Transfer Office, represents a significant gathering for Utah's life sciences community, which includes medical device manufacturing, biotechnology, biopharmaceuticals, and diagnostics sectors. Early registration discounts are available through February 15, providing cost savings for attendees interested in networking and investment opportunities.
The summit's importance lies in its focus on connecting entrepreneurs with investors in a critical industry that drives both Utah's economy and healthcare advancements. On March 12, the conference will be held at the Hilton Hotel in Salt Lake City, followed by a ski day and luncheon at Snowbird Ski Resort on March 13, combining professional development with informal networking. A key highlight will be a presentation by Monica DiCenso, managing director and head of the global investment opportunities group at J.P. Morgan Private Bank, who will discuss the life sciences investment landscape and outlook, offering valuable insights for stakeholders navigating market trends.
Another notable feature is a Shark Tank-style life sciences pitch competition, where winners will receive a cash prize, fostering innovation and potentially launching new ventures. This competition underscores the event's role in supporting early-stage companies and technologies, which are essential for advancing healthcare solutions. The partnership between BioUtah, an independent trade association, and BYU's academic and technology transfer arms emphasizes the collaboration between industry and academia in translating research into practical applications.
For more details, the full announcement can be accessed at https://www.reportable.com. The summit's implications extend beyond Utah, as it may influence investment flows and innovation in the broader life sciences industry, impacting healthcare outcomes globally. By facilitating connections and knowledge sharing, the event aims to accelerate the development of new technologies and treatments, making it a pivotal moment for entrepreneurs, investors, and researchers alike.
